<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>CatsWannaBeCats.Com | Templeton Gibbons | Activity</title>
	<link>https://www.catswannabecats.com/members/skyview3/activity/</link>
	<atom:link href="https://www.catswannabecats.com/members/skyview3/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for Templeton Gibbons.</description>
	<lastBuildDate>Wed, 01 Jul 2026 18:37:05 -0400</lastBuildDate>
	<generator>https://buddypress.org/?v=7.2.0</generator>
	<language>en-CA</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">44536db04771522a7835fc90a16d0db0</guid>
				<title>Templeton Gibbons posted an update: 6%) were women. Single session of Savary-Gilliard bougie [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/23281/</link>
				<pubDate>Sun, 08 Jun 2025 08:35:06 -0400</pubDate>

									<content:encoded><![CDATA[<p>6%) were women. Single session of Savary-Gilliard bougie dilation was successful in 90.7% of patients in relieving dysphagia and 9.3% developed recurrence, requiring repeated dilations. Four patients had concomitant squamous cell carcinoma of esophagus along with PVS and two developed upper gastrointestinal malignancy during follow-up. Conclusion&hellip;<span class="activity-read-more" id="activity-read-more-23281"><a href="https://www.catswannabecats.com/activity/p/23281/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">16ee12d4b08af89fcff94a271f2512c0</guid>
				<title>Templeton Gibbons posted an update: Bone patellar tendon bone autograft was used in 178 (30%) [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/11791/</link>
				<pubDate>Sun, 01 Jun 2025 08:09:39 -0400</pubDate>

									<content:encoded><![CDATA[<p>Bone patellar tendon bone autograft was used in 178 (30%) patients while hamstring tendon autograft was used in the rest 415 (70%) of the study population, during this period. Statistical analysis revealed a significantly reduced postoperative infection rate (p = 0.018) between the two reported periods, with the main impact referring to the use&hellip;<span class="activity-read-more" id="activity-read-more-11791"><a href="https://www.catswannabecats.com/activity/p/11791/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">4b9ca82217a6b2a302f9370153303493</guid>
				<title>Templeton Gibbons posted an update: RESULTS Among 23 participants with CF, improvements in [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/5246/</link>
				<pubDate>Sat, 31 May 2025 14:38:30 -0400</pubDate>

									<content:encoded><![CDATA[<p>RESULTS Among 23 participants with CF, improvements in frailty and lung function were independently associated with improved disability and some HRQL measures. For example, each 1-point improvement in SPPB or 200 mL improvement in FEV1 was associated with improved LT-VLA disability by 0.14 (95%CI 0.08-0.20) and 0.07 (95%CI 0.05-0.09) points and i&hellip;<span class="activity-read-more" id="activity-read-more-5246"><a href="https://www.catswannabecats.com/activity/p/5246/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">06681e90e1bac0492e313db13906dc3f</guid>
				<title>Templeton Gibbons became a registered member</title>
				<link>https://www.catswannabecats.com/activity/p/5050/</link>
				<pubDate>Sat, 31 May 2025 14:25:21 -0400</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>